MEDAVAIL HOLDINGS INC's ticker is MDVL and the CUSIP is 58406B103. A total of 28 filers reported holding MEDAVAIL HOLDINGS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $245,100 | -14.5% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $286,600 | -4.4% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $299,800 | -61.4% | 1,000,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $776,000 | -49.3% | 1,000,000 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $1,530,000 | +57.6% | 1,000,000 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $971,000 | -30.6% | 1,000,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $1,400,000 | -63.9% | 1,000,000 | -24.7% | 0.00% | -62.5% |
| Q3 2021 | $3,878,000 | -82.7% | 1,328,083 | -27.4% | 0.01% | -81.8% |
| Q2 2021 | $22,394,000 | -12.5% | 1,828,083 | 0.0% | 0.04% | -15.4% |
| Q1 2021 | $25,593,000 | -22.6% | 1,828,083 | -16.7% | 0.05% | -27.8% |
| Q4 2020 | $33,045,000 | – | 2,195,702 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 15,029,480 | $22,995,000 | 81.12% |
| Ally Bridge Group (NY) LLC | 5,894,897 | $9,019,000 | 8.22% |
| Redmile Group, LLC | 25,192,751 | $38,545,000 | 1.47% |
| CIGNA INVESTMENTS INC /NEW | 2,389,478 | $3,656,000 | 0.73% |
| Alyeska Investment Group, L.P. | 7,529,411 | $11,520,000 | 0.13% |
| PURA VIDA INVESTMENTS, LLC | 714,120 | $1,093,000 | 0.06% |
| Alpha Paradigm Partners, LLC | 57,539 | $88,000,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 836,626 | $1,280,000 | 0.03% |
| Belvedere Trading LLC | 242,100 | $332,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $1,530,000 | 0.00% |